Carbapenem Therapeutic Drug Monitoring in Critically Ill Adult Patients and Clinical Outcomes: A Systematic Review with Meta-Analysis
Drug monitoring is one strategy of antibiotic stewardship to face antimicrobial resistance. This strategy could have a determinant role in critically ill patients treated with carbapenems to overcome pharmacokinetic variability, reduce the risk of subtherapeutic dosage or toxicity, and reduce the ri...
Saved in:
Main Authors: | Sharon Lechtig-Wasserman (Author), Hans Liebisch-Rey (Author), Nicolas Diaz-Pinilla (Author), Jhosep Blanco (Author), Yuli-Viviana F (Author), Rosa-Helena Bustos (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Administration and Therapeutic Drug Monitoring of <i>β-lactams</i> and Vancomycin in Critical Care Units in Colombia: The ANTIBIOCOL Study
by: Yuli V. Fuentes, et al.
Published: (2021) -
Carbapenem Utilization in Critically Ill Patients
by: Shahrzad Mahini, et al.
Published: (2015) -
Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients
by: Julie Gorham, et al.
Published: (2023) -
Biologics in COVID-19 So Far: Systematic Review
by: Milton Arias, et al.
Published: (2022) -
Therapeutic Drug Monitoring of Vancomycin Following Critical Care Illnesses: Peak Concentration Determination Maybe Critical
by: Bita Shahrami, et al.
Published: (2015)